These protocols are used to induce high degree of metaphase synchrony in meristem root-tip cells. The procedures use a combination of hydroxyurea, a DNA synthesis inhibitor, and the anti-microtubular drug amiprophos-methyl or oryzalin. The original version of the procedure has been published by Dolezel et al. (1992).
